RT Journal Article
SR Electronic
T1 Changes in RT-PCR-positive SARS-CoV-2 rates in adults and children according to the epidemic stages
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.18.20098863
DO 10.1101/2020.05.18.20098863
A1 Levy, Corinne
A1 Basmaci, Romain
A1 Bensaid, Philippe
A1 Bru, Cécile Bost
A1 Coinde, Edeline
A1 Dessioux, Emmanuelle
A1 Fournial, Cécile
A1 Gashignard, Jean
A1 Haas, Hervé
A1 Hentgen, Véronique
A1 Huet, Frédéric
A1 Lalande, Muriel
A1 Martinot, Alain
A1 Pons, Charlotte
A1 Romain, Anne Sophie
A1 Ursulescu, Nicoleta
A1 Sage, François Vie Le
A1 Raymond, Josette
A1 Béchet, Stéphane
A1 Toubiana, Julie
A1 Cohen, Robert
YR 2020
UL http://medrxiv.org/content/early/2020/06/09/2020.05.18.20098863.abstract
AB Aim To describe the trends of RT-PCR positive SARS-CoV-2 rates in children and adults according to the time of COVID-19 epidemic.Methods In this prospective multicenter study involving 45 pediatric units, we collected the results of nasopharyngeal swabs in France from March 2, 2020 to April 26, 2020.Results During the study period, 52,588 RT-PCR tests for SARS-CoV-2 were performed, 6,490 in children and 46,098 in adults. The risk ratio of RT-PCR positive SARS-CoV-2 tests for adults compared to children was 3.5 (95% CI [3.2;3.9]) for the whole study period. These rates varied according to the time of the epidemic and were higher at the peak. The lower rates of positive test in children persisted during the surveillance period but varied according to the time in the epidemic.Conclusion The rate of positive RT-PCR positive SARS-CoV-2 tests for children was always less than that for adults but vary according to the epidemic stage.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot registeredFunding StatementNo fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The GFHGNP (Groupe Francophone Hepatologie et Nutrition Pediatrique) Ethics Comittee, certifies that this study Surveillance of SARS CoV2 positive PCR in France performed by the GPIP ACTIV does not required any ethical approval due to the absence of personal dataAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesdata are available upon reasonable request